Regarding CXCL11, GSK690693 (4.82-fold reduction) and JNK-IN-8 (2.72-fold reduction) each significantly reduced CXCL11 induction in response to infection as compared to infected cells treated with vehicle alone (Figure 5E,F). Here, CXCL11 is linked to infection.